Development of Hepatitis C Virus-Related Cancers
A Special Issue of Cancers (ISSN 2072-6694) belonging to the section "Clinical Research in Cancer".
Deadline for manuscript submissions: 20 September 2026 | Viewed by 1177
Editor
Interests: viral hepatitis; hepatic and extrahepatic manifestations of hepatitis viruses; mixed cryoglobulinemia; lymphoproliferative disorders; mechanisms of viral oncogenesis
Special Issue Information
Dear Colleagues,
Chronic infection with hepatitis C virus (HCV) is a well-established risk factor for hepatocellular carcinoma. However, a growing body of evidence has demonstrated that HCV is also associated with a wide range of non-hepatic malignancies. Epidemiological and clinical studies have linked HCV infection with lymphoproliferative disorders, such as non-Hodgkin lymphoma, as well as certain solid tumors, including those of the pancreas, kidney, and oral cavity.
The mechanisms underlying these associations are multifactorial and may include chronic immune activation, sustained inflammation, and direct oncogenic effects of viral proteins. Understanding the broader oncogenic potential of HCV is essential for developing comprehensive screening, surveillance, and management strategies—especially in the era of direct-acting antivirals (DAAs), where long-term outcomes post SVR remain a key area of investigation.
This Special Issue aims to provide an updated overview of the oncogenic risks associated with HCV, taking into account both hepatic and extrahepatic sites, with a focus on the available pathogenetic data, the clinical relevance of these associations, and their implications for patient care.
Prof. Dr. Anna linda Zignego
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatitis C virus (HCV)
- hepatocellular carcinoma (HCC)
- extrahepatic malignancies
- lymphoproliferative disorders
- viral oncogenesis
- chronic inflammation and cancer
- direct-acting antivirals (DAAs)
- cancer surveillance in HCV patients
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
